FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3154792063> ?p ?o ?g. }

• W3154792063 abstract "Abstract Background It is unclear whether vasopressors can be safely administered through a peripheral intravenous (PIV). Systematic review and meta-analysis methodology was used to examine the incidence of local anatomic adverse events associated with PIV vasopressor administration in patients of any age cared for in any acute care environment. Methods MEDLINE, EMBASE, CINAHL, the Cochrane Central Register of controlled trials, and the Database of Abstracts of Reviews of Effects were searched without restriction from inception to October 2019. References of included studies and related reviews, as well as relevant conference proceedings were also searched. Studies were included if they were: (1) cohort, quasi-experimental, or randomized controlled trial study design; (2) conducted in humans of any age or clinical setting; and (3) reported on local anatomic adverse events associated with PIV vasopressor administration. Risk of bias was assessed using the Revised Cochrane risk-of-bias tool for randomized trials or the Joanna Briggs Institute checklist for prevalence studies where appropriate. Incidence estimates were pooled using random effects meta-analysis. Subgroup analyses were used to explore sources of heterogeneity. Results Twenty-three studies were included in the systematic review, of which 16 and 7 described adults and children, respectively. Meta-analysis from 11 adult studies including 16,055 patients demonstrated a pooled incidence proportion of adverse events associated with PIV vasopressor administration as 1.8% (95% CI 0.1–4.8%, I 2 = 93.7%). In children, meta-analysis from four studies and 388 patients demonstrated a pooled incidence proportion of adverse events as 3.3% (95% CI 0.0–10.1%, I 2 = 82.4%). Subgroup analyses did not detect any statistically significant effects associated with stratification based on differences in clinical location, risk of bias or design between studies, PIV location and size, or vasopressor type or duration. Most studies had high or some concern for risk of bias. Conclusion The incidence of adverse events associated with PIV vasopressor administration is low. Additional research is required to examine the effects of PIV location and size, vasopressor type and dose, and patient characteristics on the safety of PIV vasopressor administration." @default.
• W3154792063 created "2021-04-26" @default.
• W3154792063 creator A5016206619 @default.
• W3154792063 creator A5025043678 @default.
• W3154792063 creator A5044022125 @default.
• W3154792063 creator A5048091736 @default.
• W3154792063 creator A5077428434 @default.
• W3154792063 creator A5079270556 @default.
• W3154792063 creator A5082203006 @default.
• W3154792063 date "2021-04-16" @default.
• W3154792063 modified "2023-10-04" @default.
• W3154792063 title "Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis" @default.
• W3154792063 cites W1962642315 @default.
• W3154792063 cites W1977915428 @default.
• W3154792063 cites W1990297005 @default.
• W3154792063 cites W2019759957 @default.
• W3154792063 cites W2031608109 @default.
• W3154792063 cites W2074225649 @default.
• W3154792063 cites W2087846846 @default.
• W3154792063 cites W2094844278 @default.
• W3154792063 cites W2133564174 @default.
• W3154792063 cites W2136111108 @default.
• W3154792063 cites W2149206813 @default.
• W3154792063 cites W2149635843 @default.
• W3154792063 cites W2156098321 @default.
• W3154792063 cites W2158514421 @default.
• W3154792063 cites W2159311456 @default.
• W3154792063 cites W2165721969 @default.
• W3154792063 cites W2299177375 @default.
• W3154792063 cites W2330487141 @default.
• W3154792063 cites W2340855875 @default.
• W3154792063 cites W2417616718 @default.
• W3154792063 cites W2574261120 @default.
• W3154792063 cites W2620966495 @default.
• W3154792063 cites W2707099953 @default.
• W3154792063 cites W2747628283 @default.
• W3154792063 cites W2757089737 @default.
• W3154792063 cites W2765781679 @default.
• W3154792063 cites W2785755264 @default.
• W3154792063 cites W2965390203 @default.
• W3154792063 cites W2970684805 @default.
• W3154792063 cites W2979072676 @default.
• W3154792063 cites W2979776779 @default.
• W3154792063 cites W2983935547 @default.
• W3154792063 cites W2991426041 @default.
• W3154792063 cites W2991792334 @default.
• W3154792063 cites W2997855259 @default.
• W3154792063 cites W3005429114 @default.
• W3154792063 cites W3005744162 @default.
• W3154792063 cites W3011908336 @default.
• W3154792063 cites W3016555942 @default.
• W3154792063 cites W61855402 @default.
• W3154792063 doi "https://doi.org/10.1186/s13054-021-03553-1" @default.
• W3154792063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8050944" @default.
• W3154792063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33863361" @default.
• W3154792063 hasPublicationYear "2021" @default.
• W3154792063 type Work @default.
• W3154792063 sameAs 3154792063 @default.
• W3154792063 citedByCount "34" @default.
• W3154792063 countsByYear W31547920632021 @default.
• W3154792063 countsByYear W31547920632022 @default.
• W3154792063 countsByYear W31547920632023 @default.
• W3154792063 crossrefType "journal-article" @default.
• W3154792063 hasAuthorship W3154792063A5016206619 @default.
• W3154792063 hasAuthorship W3154792063A5025043678 @default.
• W3154792063 hasAuthorship W3154792063A5044022125 @default.
• W3154792063 hasAuthorship W3154792063A5048091736 @default.
• W3154792063 hasAuthorship W3154792063A5077428434 @default.
• W3154792063 hasAuthorship W3154792063A5079270556 @default.
• W3154792063 hasAuthorship W3154792063A5082203006 @default.
• W3154792063 hasBestOaLocation W31547920631 @default.
• W3154792063 hasConcept C118552586 @default.
• W3154792063 hasConcept C120665830 @default.
• W3154792063 hasConcept C121332964 @default.
• W3154792063 hasConcept C126322002 @default.
• W3154792063 hasConcept C15744967 @default.
• W3154792063 hasConcept C168563851 @default.
• W3154792063 hasConcept C17744445 @default.
• W3154792063 hasConcept C177713679 @default.
• W3154792063 hasConcept C180747234 @default.
• W3154792063 hasConcept C187960798 @default.
• W3154792063 hasConcept C189708586 @default.
• W3154792063 hasConcept C194828623 @default.
• W3154792063 hasConcept C197934379 @default.
• W3154792063 hasConcept C199539241 @default.
• W3154792063 hasConcept C201903717 @default.
• W3154792063 hasConcept C27415008 @default.
• W3154792063 hasConcept C2779356329 @default.
• W3154792063 hasConcept C2779473830 @default.
• W3154792063 hasConcept C2781145037 @default.
• W3154792063 hasConcept C61511704 @default.
• W3154792063 hasConcept C71924100 @default.
• W3154792063 hasConcept C95190672 @default.
• W3154792063 hasConceptScore W3154792063C118552586 @default.
• W3154792063 hasConceptScore W3154792063C120665830 @default.
• W3154792063 hasConceptScore W3154792063C121332964 @default.
• W3154792063 hasConceptScore W3154792063C126322002 @default.
• W3154792063 hasConceptScore W3154792063C15744967 @default.
• W3154792063 hasConceptScore W3154792063C168563851 @default.
• W3154792063 hasConceptScore W3154792063C17744445 @default.

• next